Chris Mirabile is the Founder and CEO of NOVOS, a company advancing evidence-based solutions to slow biological aging. His passion for longevity began after surviving a brain tumor at sixteen, an experience that revealed how limited practical guidance existed for people seeking to improve their long-term health. Determined to change that, he has since achieved measurable results himself, including a 37% slower pace of aging according to epigenetic, metabolomic, and physiological markers, which he achieved through data- and research-driven interventions.
In partnership with 
